Direct activation of forkhead box O3 by tumor suppressors p53 and p73 is disrupted during liver regeneration in mice

Hepatology

Volumn 52, Issue 3, 2010, Pages 1023-1032

  Kurinna, Svitlana ^a,b   Stratton, Sabrina A ^b   Tsai, Wen Wei ^b   Akdemir, Kadir C ^b   Gu, Weisong ^c   Singh, Pallavi ^d   Goode, Triona ^e   Darlington, Gretchen J ^e   Barton, Michelle Craig ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c OHIO SUPERCOMPUTER CENTER   (United States)

^d College of Physicians and Surgeons ^*  (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; HISTONE; PROTEIN P300; PROTEIN P53; PROTEIN P73; TRANSCRIPTION FACTOR FKHRL1; DELTA NP73, MOUSE; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, MOUSE; HISTONE ACETYLTRANSFERASE PCAF; NUCLEAR PROTEIN; P300-CBP-ASSOCIATED FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL FUNCTION; CELL PROLIFERATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; EMBRYO; ENZYME ACTIVATION; FIBROBLAST; GENE CONTROL; GENE EXPRESSION PROFILING; GENE TARGETING; GROWTH REGULATION; HEPATOMA CELL; LIVER REGENERATION; LIVER RESECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; TISSUE REGENERATION; TRANSCRIPTION INITIATION; ANIMAL; C57BL MOUSE; CELL CULTURE; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; SURGERY; TUMOR CELL LINE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELLS, CULTURED; FIBROBLASTS; FORKHEAD TRANSCRIPTION FACTORS; HEPATECTOMY; HISTONES; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; NUCLEAR PROTEINS; P300-CBP TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77956627143     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23746     Document Type: Article

References (41)

1. Irwin MS, Kaelin WG. p53 family update: p73 and p63 develop their own identities. Cell Growth Differ 2001;12:337-349.
2. Flores ER, Sengupta S, Miller JB, Newman JJ, Bronson R, Crowley D, et al. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 2005;7:363-373. (Pubitemid 40544653)
3. Lee KC, Crowe AJ, Barton MC. p53-mediated repression of alpha-feto-protein gene expression by specific DNA binding. Mol Cell Biol 1999;19:1279-1288.
4. Cui R, Nguyen TT, Taube JH, Stratton SA, Feuerman MH, Barton MC. Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription. J Biol Chem 2005;280:39152-39160.
5. Tsai WW, Nguyen TT, Shi Y, Barton MC. p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo. Mol Cell Biol 2008;28:5139-5146.
6. Fontemaggi G, Kela I, Amariglio N, Rechavi G, Krishnamurthy J, Strano S, et al. Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses. J Biol Chem 2002;277:43359-43368. (Pubitemid 35285724)
7. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997;276:60-66.
8. Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, et al. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol 2008;10:138-148.
9. Nowak K, Killmer K, Gessner C, Lutz W. E2F-1 regulates expression of FOXO1 and FOXO3a. Biochim Biophys Acta 2007;1769:244-252.
10. Essaghir A, Dif N, Marbehant CY, Coffer PJ, Demoulin JB. The transcription of FOXO genes is stimulated by FOXO3 and repressed by growth factors. J Biol Chem 2009;284:10334-10342.
11. Partial hepatectomy. CSH Protoc; doi:10.1101/pdb.prot4384.
12. Wilkinson DS, Tsai WW, Schumacher MA, Barton MC. Chromatin-bound p53 anchors activated Smads and the mSin3A corepressor to confer transforming-growth-factor-beta-mediated transcription repression. Mol Cell Biol 2008;28:1988-1998.
13. Murphy M, Hinman A, Levine AJ. Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev 1996;10:2971-2980. (Pubitemid 26412524)
14. Gene Expression Omnibus. Accession number GSE20427. http://www.ncbi.nlm. nih.gov/geo/query/acc.cgi?acc=GSE20427. Accessed May 2010.
15. Ingenuity Systems. Ingenuity Pathway Analysis. http://www.ingenuity.com. Accessed May 2010.
16. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, Daverman R, et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 2003;13:2129-2141.
17. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
18. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 2000;404:99-103.
19. Talos F, Nemajerova A, Flores ER, Petrenko O, Moll UM. p73 suppresses polyploidy and aneuploidy in the absence of functional p53. Mol Cell 2007;27:647-659. (Pubitemid 47238632)
20. Lecona E, Barrasa JI, Olmo N, Llorente B, Turnay J, Lizarbe MA. Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase. Mol Cell Biol 2008;28:4665-4674.
21. Secchiero P, Melloni E, di Iasio MG, Tiribelli M, Rimondi E, Corallini F, et al. Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism. Blood 2009;113:4300-4308.
22. Nishimori H, Shiratsuchi T, Urano T, Kimura Y, Kiyono K, Tatsumi K, et al. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene 1997;15:2145-2150.
23. Su AI, Guidotti LG, Pezacki JP, Chisari FV, Schultz PG. Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice. Proc Natl Acad Sci U S A 2002;99:11181-11186.
24. White P, Brestelli JE, Kaestner KH, Greenbaum LE. Identification of transcriptional networks during liver regeneration. J Biol Chem 2005;280:3715-3722. (Pubitemid 40223839)
25. Hoh J, Jin S, Parrado T, Edington J, Levine AJ, Ott J. The p53MH algorithm and its application in detecting p53-responsive genes. Proc Natl Acad Sci U S A 2002;99:8467-8472.
26. Nguyen TT, Cho K, Stratton SA, Barton MC. Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene. Mol Cell Biol 2005;25:2147-2157.
27. Bourdon JC, Fernandes K, Murray-Zmijewski F, Liu G, Diot A, Xirodimas DP, et al. p53 isoforms can regulate p53 transcriptional activity. Genes Dev 2005;19:2122-2137.
28. Darlington GJ, Tsai CC, Samuelson LC, Gumucio DL, Meisler MH. Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. Mol Cell Biol 1986;6:969-975.
29. Ueda Y, Hijikata M, Takagi S, Chiba T, Shimotohno K. Transcriptional activities of p73 splicing variants are regulated by inter-variant association. Biochem J 2001;356:859-866. (Pubitemid 32588459)
30. Ueda Y, Hijikata M, Takagi S, Chiba T, Shimotohno K. New p73 variants with altered C-terminal structures have varied transcriptional activities. Oncogene 1999;18:4993-4998.
31. Lokshin M, Li Y, Gaiddon C, Prives C. p53 and p73 display common and distinct requirements for sequence specific binding to DNA. Nucleic Acids Res 2007;35:340-352.
32. Greer EL, Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 2005;24:7410-7425. (Pubitemid 41637981)
33. Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 1997;89:1175-1184.
34. Zeng X, Li X, Miller A, Yuan Z, Yuan W, Kwok RP, et al. The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis. Mol Cell Biol 2000;20:1299-1310.
35. Smeenk L, van Heeringen SJ, Koeppel M, van Driel MA, Bartels SJ, Akkers RC, et al. Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res 2008;36:3639-3654.
36. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008;9:402-412. (Pubitemid 351574202)
37. Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, Pandolfi PP. Identification of a tumour suppressor network opposing nuclear Akt function. Nature 2006;441:523-527.
38. You H, Yamamoto K, Mak TW. Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a. Proc Natl Acad Sci U S A 2006;103:9051-9056.
39. Wang F, Marshall CB, Yamamoto K, Li GY, Plevin MJ, You H, et al. Biochemical and structural characterization of an intramolecular interaction in FOXO3a and its binding with p53. J Mol Biol 2008;384:590-603.
40. Albrecht JH, Meyer AH, Hu MY. Regulation of cyclin-dependent kinase inhibitor p21 (WAF1/Cip1/Sdi1) gene expression in hepatic regeneration. HEPATOLOGY 1997;25:557-563. (Pubitemid 27106433)
41. Directory of p53 consensus DNA binding sites. http://linkage.rockefeller. edu/p53. Accessed May 2010.